Stay updated on Panitumumab, Nivolumab, Ipilimumab in mCRC Clinical Trial
Sign up to get notified when there's something new on the Panitumumab, Nivolumab, Ipilimumab in mCRC Clinical Trial page.

Latest updates to the Panitumumab, Nivolumab, Ipilimumab in mCRC Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page’s footer revision label was updated from v3.5.2 to v3.5.3, indicating a minor update to the ClinicalTrials.gov page version rather than study details.SummaryDifference0.1%

- Check24 days agoChange DetectedRevision update: from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check53 days agoChange DetectedRevision history updated: added Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.1%

- Check67 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3; no visible changes to study details or navigation were observed.SummaryDifference0.1%

- Check89 days agoChange DetectedRevision: v3.4.2 was added to the page footer. Revision: v3.4.1 was removed.SummaryDifference0.1%

- Check96 days agoChange DetectedRevision history updated: a new entry for v3.4.1 was added and the existing entry for v3.4.0 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Panitumumab, Nivolumab, Ipilimumab in mCRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Panitumumab, Nivolumab, Ipilimumab in mCRC Clinical Trial page.